| Update on CSF biomarkers in Parkinson’s disease EH Kwon, S Tennagels, R Gold, K Gerwert, L Beyer, L Tönges Biomolecules 12 (2), 329, 2022 | 61 | 2022 |
| Association of plasma biomarkers, p‐tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long‐term clinical Alzheimer's disease risk: results … H Stocker, L Beyer, L Perna, D Rujescu, B Holleczek, K Beyreuther, ... Alzheimer's & Dementia 19 (1), 25-35, 2023 | 58 | 2023 |
| Association of kidney function with development of Alzheimer disease and other dementias and dementia-related blood biomarkers H Stocker, L Beyer, K Trares, L Perna, D Rujescu, B Holleczek, ... JAMA network open 6 (1), e2252387-e2252387, 2023 | 55 | 2023 |
| Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years L Beyer, H Stocker, D Rujescu, B Holleczek, J Stockmann, A Nabers, ... Alzheimer's & Dementia 19 (3), 1020-1028, 2023 | 49 | 2023 |
| TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis L Beyer, R Günther, JC Koch, S Klebe, T Hagenacker, P Lingor, ... Annals of Clinical and Translational Neurology 8 (1), 271-277, 2021 | 28 | 2021 |
| The effect of (−)-epigallocatechin-3-gallate on the amyloid-β secondary structure A Acharya, J Stockmann, L Beyer, T Rudack, A Nabers, JC Gumbart, ... Biophysical Journal 119 (2), 349-359, 2020 | 24 | 2020 |
| Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over … H Stocker, K Trares, L Beyer, L Perna, D Rujescu, B Holleczek, ... Alzheimer's Research & Therapy 15 (1), 129, 2023 | 21 | 2023 |
| Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study L Perna, H Stocker, L Burow, L Beyer, K Trares, C Kurz, S Gürsel, ... Alzheimer's research & therapy 15 (1), 198, 2023 | 7 | 2023 |
| Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy PL Poser, GS Sajid, L Beyer, A Hieke, A Schumacher, L Horstkemper, ... European Journal of Neurology 31 (1), e16023, 2024 | 4 | 2024 |
| High cholesterol levels change the association of biomarkers of neurodegenerative diseases with dementia risk: Findings from a population‐based cohort L Perna, U Mons, H Stocker, L Beyer, K Beyreuther, K Trares, B Holleczek, ... Alzheimer's & Dementia 19 (7), 2913-2922, 2023 | 4 | 2023 |
| Mitochondrial DNA abundance in blood is associated with Alzheimer’s disease-and dementia-risk H Stocker, M Gentiluomo, K Trares, L Beyer, J Stevenson-Hoare, ... Molecular psychiatry 30 (1), 131-139, 2025 | 2 | 2025 |
| Warum ist die Früherkennung von Alzheimer wichtig? L Beyer, K Gerwert Disease Interception als Chance und Herausforderung, 69-90, 2024 | 2 | 2024 |
| The association between plasma biomarkers, p‐tau181, glial fibrillary acidic protein, and neurofilament light and clinical AD risk: Results from prospective cohort study … H Stocker, L Beyer, L Perna, B Schöttker, KB Gerwert, H Brenner Alzheimer's & Dementia 17, e057547, 2021 | 1 | 2021 |
| Alpha-synuclein misfolding as a fluid biomarker for Parkinson’s disease and synucleinopathies measured with the iRS platform M Schuler, G Gerwert, M Mann, N Woitzik, L Langenhoff, D Hubert, ... medRxiv, 2024.09. 02.24312694, 2024 | | 2024 |
| Characterization of axonal damage and inflammation in CIDP L Horstkemper, M Schröder, J Oebbeke, AR Grießmann, A Hieke, ... Clinical Neurophysiology 159, e34-e35, 2024 | | 2024 |
| A structure‐based fluid biomarker for the differential diagnosis of early‐stage neurodegenerative diseases measured by the immuno‐infrared‐sensor (iRS) M Schuler, M Mann, LC Langenhoff, B Budde, L Beyer, N Woitzik, ... Alzheimer's & Dementia 19, e082847, 2023 | | 2023 |
| Serum-Neurofilament light chain levels in secondary progressive multiple sclerosis are associated with grey matter destruction characterized by relaxation rates R Schneider, T Ladopoulos, B Bellenberg, L Beyer, S Faissner, R Gold, ... MULTIPLE SCLEROSIS JOURNAL 29, 283-284, 2023 | | 2023 |
| Kidney function is associated to Alzheimer’s related blood biomarkers (NfL, P‐tau181, and GFAP) but not dementia risk in a community‐based cohort followed over 17 years H Stocker, L Beyer, K Trares, L Perna, D Rujescu, B Holleczek, ... Alzheimer's & Dementia 18, e069248, 2022 | | 2022 |
| JOINT CONTRIBUTION OF MARKERS OF NEURODEGENERATION AND HYPERCHOLESTEROLEMIA TO DEMENTIA RISK L Perna, U Mons, H Stocker, L Beyer, K Beyreuther, K Trares, B Holleczek, ... medRxiv, 2022.01. 16.22269370, 2022 | | 2022 |
| Generation of mid‐region murine monoclonal antibodies against multiple structural isoforms of amyloid‐beta by hybridoma technology: Biomarkers (non‐neuroimaging)/plasma/serum … J Stockmann, L Beyer, S Galkowski, N Woitzik, J Güldenhaupt, ... Alzheimer's & Dementia 16, e043577, 2020 | | 2020 |
